Early research (Phase 1)WithdrawnNCT02757248What this trial is testingPh1 Volasertib Plus Romidepsin in R/R PTCL and CTCLWho this might be right forPTCLCTCL Anne Beaven, MD
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40
Very early researchUnknownNCT04767308What this trial is testingSafety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic MalignanciesWho this might be right forCD5+ Relapsed/Refractory Hematopoietic MalignanciesChronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)+3 more Huazhong University of Science and Technology 18
Early research (Phase 1)Study completedNCT01590732What this trial is testingRomidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaWho this might be right forMycosis FungoidesRecurrent Anaplastic Large Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma+8 more M.D. Anderson Cancer Center 22
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00406809What this trial is testingABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesWho this might be right forChronic Lymphoid LeukemiaLymphoid MalignanciesNon-Hodgkin's Lymphoma+3 more AbbVie (prior sponsor, Abbott) 81
Early research (Phase 1)Study completedNCT01871675What this trial is testingStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesWho this might be right forLymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+1 more SCRI Development Innovations, LLC 48
Not applicableStudy completedNCT04213209What this trial is testingSpecial Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"Who this might be right forPeripheral T Cell LymphomaPediatric Hodgkin Lymphoma Takeda 95
Large-scale testing (Phase 3)Study completedNCT00719563What this trial is testingAmerican Ginseng in Treating Patients With Fatigue Caused by CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+7 more Alliance for Clinical Trials in Oncology 364
Testing effectiveness (Phase 2)Looking for participantsNCT07093710What this trial is testingGolidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell LymphomaWho this might be right forPeripheral T Cell Lymphoma Sun Yat-sen University 101
Early research (Phase 1)UnknownNCT03921879What this trial is testingSafety and Efficacy of OT-82 in Participants With Relapsed or Refractory LymphomaWho this might be right forLymphomaLymphoma, Non-HodgkinLymphoma, B-Cell+4 more Oncotartis, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Early research (Phase 1)WithdrawnNCT02238522What this trial is testingPhase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AMLWho this might be right forLymphoproliferative MalignanciesAcute Myeloid Leukemia Zenith Epigenetics
Testing effectiveness (Phase 2)Looking for participantsNCT06839456What this trial is testingPhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCTWho this might be right forLeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more Children's Hospital of Philadelphia 100
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00109993What this trial is testingCampath-1H + FK506 and Methylprednisolone for GVHDWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00827099What this trial is testingUmbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+2 more Northside Hospital, Inc. 5
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252